STAT3 and Alzheimer disease: Treatment with a specific STAT3 inhibitor has demonstrated a reduction in neuroinflammatory plaques, cerebral amyloid angiopathy, oxidative stress, and neuroinflammation in experimental animal models of AD, leading to improved cognitive function and a protective effect on neurovascular function [49].